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etter to the Editorstimating  risk  factors  for acinetobacter  bacteremia  in
automated system. Susceptibility of the isolates by deter-ediatric settings
ear Editor,
osocomial invasive infections due to Acinetobacter species are
radually increasing in the health care settings especially in
ntensive care units (ICUs).1
This retrospective study is designed to investigate risk
actors  associated with Acinetobacter bacteremia among chil-
ren  hospitalized in Dr. Behc¸et  Uz Children’s Hospital, during
005–2011.  Nosocomial bacteremia was  deﬁned as isolation of
cinetobacter  spp. obtained from blood 72 h after admission to
Table 1 – Cases of bacteremia × control cases (non-bacteremia).
Characteristics Cases of bacterem
Acinetobact
(n = 35) 
Demographic parameters
Age,  months, median (IQR) 7 (1–172) 
Male gender, n (%) 21 (60) 
Concomitant illness, n (%)
Prematurity  10 (28.6) 
Neurometabolic diseases 10 (28.6) 
Hematologic malignancy 4 (11.4) 
Congenital cardiac disease 3 (8.6) 
Chronic lung disease 2 (5.7) 
Renal insufﬁciency 2 (5.7) 
Immunosuppressive status 4 (11.4) 
Neutropenia 5 (14.3) 
Duration (days), median (IQR)
Of  hospitalization 24 (6–359) 
From hospitalization to bacteremia 13 (4–288) 
Invasive procedures, n (%)
Urinary  catheter 3  (8.6) 
Central venous catheter 6 (17.1) 
Nasogastric tube 19 (54.3) 
Mechanical ventilation 14 (40) 
Thoracic drainage 2 (5.7) 
Peritoneal dialysis 1 (2.9) 
Major surgery 3 (8.6) 
Prolonged antibacterial use >10 days, n (%) 18 (51.4) 
Prolonged hospital stay >20 days, n (%) 24 (68.6) 
Mortality rates, n (%) 11 (31.4) the hospital in the presence of infection. The control group
was  randomly recruited from the age-matched patients who
had  no fever or clinical deterioration after the hospitalization
more  than 72 h.
Identiﬁcation of Acinetobacter spp. in blood samples
was performed using a Bact-Alert (bioMérieux, France)ia with
er
Control  cases
(non-bacteremic)
p
(n = 70)
4.5 (1–169) 0.95
34 (48.6) 0.26
21 (30) 0.88
6 (8.6) <0.01
2 (2.9) 0.09
11 (15.7) 1
4 (5.7) 1.00
4 (5.7) 1.00
9 (12.9) 1.00
6 (8.6) 0.50
16 (3–169) 0.01
11 (3–282) 0.62
5 (7.1) 1.00
2 (2.9) 0.01
23 (32.9) 0.03
21 (3.0) 0.30
2 (2.9) 0.59
1 (1.4) 1.00
1 (1.4) 0.10
50 (71.4) 0.05
30 (42.9) 0.01
20 (28.6) 0.76
mination of the minimum inhibitory concentrations was
performed  by VITEK2 (bioMérieux, France) compact sys-
tem.
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The 2 and Fisher’s exact test were used to evaluate the
association between categorical quantitative variables and
Student’s  t-test or Mann–Whitney-U test for continuous vari-
ables.
A  total of 35 patients and 70 control patients without
bacteremia were  included in this retrospective case–control
study. The patients had the following diagnosis: primary
bacteremia 9 (25.7%), pneumonia 9 (25.7%), central-catheter
related infection 7 (20%), peritonitis, urinary tract infection,
cerebrospinal ﬂuid infection, and post-burn wound infec-
tion.
There  was  no signiﬁcant difference in terms of gen-
der,  age, prior history of hospitalization or concomitant
illness except underlying neurometabolic disease (p > 0.05).
Length  of hospital stay was  statistically higher in patients
with  bacteremia than in control patients [24 days (6–359)
for  patients, 16 days (3–169) for controls (p = 0.01)]. Fur-
ther  analysis indicated that presence of central venous
catheter, nasogastric tube, prolonged use of antibiotics,
hospitalization for >10 days, and concomitant neu-
rometabolic disease (p < 0.05) were  signiﬁcantly more  frequent
among  patients compared to the control group (p < 0.05)
(Table  1).
Risk  factors of mortality in Acinetobacter bacteremia are
male  gender, prior use of carbapenems and glycopeptides
antibiotics, mechanical ventilation and gentamicin resistance
of  the isolate.
Several studies reported the risk factors for Acinetobacter
bacteremia especially in ICUs. Among these studies, length
of  stay in ICU, previous use of antimicrobials, mechanical
ventilation, male gender, neurologic impairment, prior colo-
nization,  and presence of excess intravascular devices were
found  to be independent risk factors for bacteremia.2–5 In our
study,  the ratio of children having central venous catheter,
nasogastric tube and concomitant neurometabolic disease
were  found to be higher compared to control group. Plus the
Acinetobacter  group was  found to have longer length of hos-
pitalization and longer antibiotic usage, compared to control
group  (p > 0.05).
Central venous catheter and nasogastric tube insertions
were  found to be risk factors for bacteremia. Central venous
catheterization was  inserted in 17.1% of the patients with
Acinetobacter bacteremia, and in only 2.9% of the control group
(p  = 0.01).In conclusion central venous catheter insertion, long
length of stay, prolonged use of antibiotics, and concomi-
tant  neurometabolic disease were  risk factors for the presence
of  bacteremia. Male gender, prior use of carbapenems and 1 3;1  7(4):505–506
glycopeptides antibiotics, use of mechanical ventilation and
gentamicin  resistance of the isolates were  also found to be
risk  factors of mortality in Acinetobacter bacteremia.
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